Department of Pediatrics, Rush University Children's Hospital, Chicago, Illinois, USA.
Chicago Department of Public Health, Chicago, Illinois, USA.
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):519-522. doi: 10.1093/jpids/piaa070.
To date, no report on coronavirus disease 2019 (COVID-19) pediatric patients in a large urban center with data on underlying comorbidities and coinfection for hospitalized cases has been published.
This was a case series of Chicago COVID-19 patients aged 0-17 years reported to the Chicago Department of Public Health (CDPH) from March 5 to April 8, 2020. Enhanced case investigation was performed. χ 2 and Wilcoxon 2-sample tests were used to compare characteristics among hospitalized and nonhospitalized cases.
During March 5-April 8, 2020, 6369 laboratory-confirmed cases of COVID-19 were reported to CDPH; 64 (1.0%) were among children aged 0-17 years. Ten patients (16%) were hospitalized, and 7 (70%) required intensive care (median length of hospitalization, 4 days [range, 1-14 days]). Reported fever and dyspnea were significantly higher in hospitalized patients than in nonhospitalized patients (9/10 vs 28/54, P = .04 and 7/10 vs 10/54, P = .002, respectively). Hospitalized patients were significantly younger than nonhospitalized patients (median, 3.5 years vs 12 years; P = .03) and all either had an underlying comorbidity or coinfection. Among the 34 unique households with multiple laboratory-confirmed infections, the median number of laboratory-confirmed infections was 2 (range, 2-5), and 31 (91%) households had at least 1 COVID-19-infected adult. For 15 households with available data to assess transmission, 11 (73%) were adult-to-child, 2 (13%) child-to-child, and 2 (13%) child-to-adult.
Enhanced case investigation of hospitalized patients revealed that underlying comorbidities and coinfection might have contributed to severe disease. Given frequency of household transmission, healthcare providers should consider alternative dispositional planning for affected families of children living with comorbidities.
迄今为止,尚无关于大城市中心新冠肺炎(COVID-19)儿科患者的报告,该报告提供了住院病例的基础合并症和合并感染的数据。
这是 2020 年 3 月 5 日至 4 月 8 日期间向芝加哥公共卫生部(CDPH)报告的年龄在 0-17 岁的芝加哥 COVID-19 患者的病例系列。对病例进行了强化调查。χ²检验和 Wilcoxon 2 样本检验用于比较住院和非住院病例的特征。
2020 年 3 月 5 日至 4 月 8 日,CDPH 报告了 6369 例实验室确诊的 COVID-19 病例;其中 10 例(1.6%)为 0-17 岁的儿童。10 例患者(16%)住院,7 例(70%)需要重症监护(住院中位数为 4 天[范围:1-14 天])。与非住院患者相比,住院患者报告的发热和呼吸困难发生率明显更高(9/10 比 28/54,P=0.04 和 7/10 比 10/54,P=0.002)。住院患者明显比非住院患者年龄小(中位数,3.5 岁比 12 岁;P=0.03),并且都有基础合并症或合并感染。在 34 个有多个实验室确诊感染的独特家庭中,实验室确诊感染的中位数为 2(范围:2-5),31 个家庭(91%)至少有 1 个 COVID-19 感染成人。对于有可用数据评估传播的 15 个家庭,11 个(73%)为成人到儿童,2 个(13%)为儿童到儿童,2 个(13%)为儿童到成人。
对住院患者的强化病例调查显示,基础合并症和合并感染可能导致疾病严重。鉴于家庭传播的频率,医护人员应考虑为患有合并症的儿童的家庭提供替代处置计划。